Anti-Hypertensive Treatment In Stable Pregnant Women With Severe Pre-Eclampsia (Metildopape)

• Status: Unknown status
• Trial end date: 2013-02-01
• Target enrollment: 0
• Participant gender: Female

Summary

Introduction: Hypertensive emergency in pregnant women with pre-eclampsia should be treated for preventing stroke and placental abruption. However, the benefit of antihypertensive medication maintenance remains unclear, mainly due to the potential risk of fetal growth restriction.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Professor Fernando Figueira Integral Medicine Institute
• Collaborator: Conselho Nacional de Desenvolvimento Científico e Tecnológico
• Treatments: Antihypertensive Agents; Methyldopa

Criteria

Inclusion Criteria:

• single pregnancy

• severe preeclampsia

• life fetus

• stable blood pressure

• gestational age between 20 weeks and 34 weeks

Exclusion Criteria:

• fetal anomalies

• antihypertensive drugs use

• others drugs use

• active labour

• tabagism

• Intra-Uterine Growth Restriction process